Survival After Combining Stereotactic Body Radiation Therapy and Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma

BACKGROUND: Stereotactic body radiation therapy (SBRT) and tyrosine kinase inhibitors (TKIs) are effective treatments for metastatic renal cell carcinoma, but data on combining these two modalities are scarce. We aimed to investigate the survival outcomes of SBRT plus TKIs. METHODS: Data of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Zhang, Zhiling, Han, Hui, Guo, Shengjie, Liu, Zhuowei, Liu, Mengzhong, Zhou, Fangjian, Dong, Pei, He, Liru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937906/
https://www.ncbi.nlm.nih.gov/pubmed/33692951
http://dx.doi.org/10.3389/fonc.2021.607595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937906/
https://www.ncbi.nlm.nih.gov/pubmed/33692951
http://dx.doi.org/10.3389/fonc.2021.607595

Ejemplares similares